Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGP-437 for Dry Eye (ALLUVION)
NCT01129856Phase 3Completed
- Sponsor
- Kiora Pharmaceuticals
- Start
- Jun 2010
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone phosphate iontophoretic ophthalmic solution in dry eye syndrome (DED), sponsored by Kiora Pharmaceuticals. Started Jun 2010; status: completed.
02
Drugs
dexamethasone phosphate iontophoretic ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01129856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129856.